| abstract |
Compound of Formula (I): wherein Ar 1 , A, R 3 , x and m are disclosed herein and Ar 2 is benzothiazolyl, benzooxazolyl or benzoimidazolyl, or they (“benzoazolyl Pharmaceutically acceptable salts of piperazine compounds ”), compositions comprising an effective amount of a benzoazolylpiperazine compound, and pain, incontinence, ulcers, inflammatory bowel disease, irritable bowel symptoms, addictive diseases, Parkinson's disease in animals, Parkinism, anxiety, epilepsy, stroke. Seizures, pruritus, psychosis, cognitive impairment, memory deficiency, limited brain function, Huntington's chorea, ALS, dementia, retinopathy, muscle cramps, migraine, vomiting, dyskinesia, or depression require an effective amount of the benzoazolylpiperazine Compound Disclosed are methods of treatment or prevention, including administration to an animal. |